PIPR Stock Analysis: Piper Sandler Companies | NYSE

Capital Markets | NYSE, USA | Market Cap: 4.640m USD | 12M Return: -23% | US7240782091 | Charts, Fundamentals & Technical Analysis

Investment Banking, Equity Research, Asset Management, Municipal Finance
Total Rating 50
Safety 77
Buy Signal -0.94
Capital Markets
Industry Rotation: -19.7
Market Cap: 4.64B
Avg Turnover: 56.4M
Risk 3d forecast
Volatility39.0%
VaR 5th Pctl6.61%
VaR vs Median2.94%
Reward TTM
Sharpe Ratio-0.66
Rel. Str. IBD10.2
Rel. Str. Peer Group21
Character TTM
Beta1.330
Beta Downside1.519
Hurst Exponent0.480
Drawdowns 3y
Max DD38.78%
CAGR/Max DD0.61
CAGR/Mean DD2.34
EPS (Earnings per Share) EPS (Earnings per Share) of PIPR over the last years for every Quarter: "2021-09": 1.14, "2021-12": 1.96, "2022-03": 0.78, "2022-06": 0.62, "2022-09": 0.22, "2022-12": 0.83, "2023-03": 0.59, "2023-06": 0.28, "2023-09": 0.44, "2023-12": 1.01, "2024-03": 0.7, "2024-06": 0.63, "2024-09": 0.64, "2024-12": 1.2, "2025-03": 1.02, "2025-06": 0.74, "2025-09": 0.96, "2025-12": 1.72, "2026-03": 1, "2026-06": 1.04,
EPS CAGR: 34.33%
EPS Trend: 99.5%
Last SUE: 1.10
Qual. Beats: 1
Revenue Revenue of PIPR over the last years for every Quarter: 2021-09: 433.621, 2021-12: 635.517, 2022-03: 343.267, 2022-06: 340.347, 2022-09: 321.23, 2022-12: 378.215, 2023-03: 289.616, 2023-06: 286.477, 2023-09: 280.514, 2023-12: 460.85, 2024-03: 333.186, 2024-06: 336.329, 2024-09: 349.725, 2024-12: 467.971, 2025-03: 347.918, 2025-06: 393.876, 2025-09: 462.371, 2025-12: 666.992, 2026-03: 475.145, 2026-06: 496.254,
Rev. CAGR: 19.67%
Rev. Trend: 97.0%
Last SUE: 0.94
Qual. Beats: 1

Warnings

Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan -1.0% 28
Feb -3.4% 8
Mar -3.6% 19
Apr -3.2% 30
May +2.3% 19
Jun -2.6% 6
Jul +2.6% 40
Aug -2.2% 8
Sep -2.6% 33
Oct +4.2% 12
Nov +7.3% 44
Dec -2.0% 14

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: PIPR Piper Sandler Companies

Piper Sandler Companies (NYSE: PIPR) is a U.S.-headquartered investment bank and institutional securities firm, founded in 1895 and based in Minneapolis, Minnesota. The company operates across two main segments: investment banking and institutional securities. It serves a broad client base that includes corporations, private equity groups, public entities, non-profit organizations, and institutional investors in the U.S. and internationally.

The firms investment banking activities span mergers and acquisitions advisory, equity and debt financings, private placements, restructuring, private capital advisory, and municipal financial advisory and underwriting. Its public finance group focuses on state and local governments, special districts, and sectors such as education, healthcare, housing, and transportation. The company was formerly known as Piper Jaffray Companies before rebranding in January 2020.

On the institutional side, Piper Sandler provides equity and fixed income sales and trading, fundamental equity and macro research, and over-the-counter derivative products. It also runs alternative asset management strategies in merchant banking and healthcare, investing both firm capital and capital from outside investors. The company sits within the investment banking and brokerage sub-industry of the financials sector, a space that typically generates revenue through transaction-based fees, advisory commissions, trading spreads, and asset management performance fees.

Headlines to Watch Out For
  • M&A advisory revenues surge on elevated corporate dealmaking activity
  • Fixed income trading weakness pressures overall segment margins
  • Public finance wins from state and local government bond issuance growth
  • Capital return via buybacks and dividends supports earnings per share growth
Piotroski VR-10 (Strict) 7.0
Net Income: 307.3m TTM > 0 and > 6% of Revenue
FCF/TA: 0.26 > 0.02 and ΔFCF/TA 24.31 > 1.0
NWC/Revenue: 27.02% < 20% (prev 25.97%; Δ 1.06% < -1%)
CFO/TA 0.27 > 3% & CFO 623.7m > Net Income 307.3m
Net Debt (30.8m) to EBITDA (515.6m): 0.06 < 3
Current Ratio: 2.09 > 1.5 & < 3
Outstanding Shares: last quarter (71.2m) vs 12m ago 0.48% < -2%
Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin)
Asset Turnover: 98.03% > 50% (prev 79.60%; Δ 18.43% > 0%)
Interest Coverage Ratio: 150.5 > 6 (EBIT TTM 487.0m / Interest Expense TTM 3.23m)
Altman Z'' 6.05
A: 0.24 (Total Current Assets 1.09b - Total Current Liabilities 518.9m) / Total Assets 2.33b
B: 0.32 (Retained Earnings 734.0m / Total Assets 2.33b)
C: 0.23 (EBIT TTM 487.0m / Avg Total Assets 2.14b)
D: 1.81 (Book Value of Equity 1.37b / Total Liabilities 759.4m)
Altman-Z'' = 6.05 = AAA
Beneish M -3.17
DSRI: 0.77 (Receivables 296.4m/285.6m, Revenue 2.10b/1.56b)
GMI: 1.03 (GM 99.63% / 96.50%)
AQI: 0.63 (AQ_t 0.45 / AQ_t-1 0.71)
SGI: 1.35 (Revenue 2.10b / 1.56b)
TATA: -0.14 (NI 307.3m - CFO 623.7m) / TA 2.33b)
Beneish M = -3.17 (Cap -4..+1) = AA
What is the price of PIPR shares?

As of October 08, 2026, the stock is trading at USD 63.79 with a total of 617,160 shares traded. Over the past week, the price has changed by -3.30%, over one month by -17.52%, over three months by -14.81% and over the past year by -22.97%.

Current recommended Stop Loss: 60.60 (which is 5% or 1.3 ATR below the current price).

Is PIPR a buy, sell or hold?

Piper Sandler Companies has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy PIPR.

  • StrongBuy: 3
  • Buy: 0
  • Hold: 1
  • Sell: 1
  • StrongSell: 0

What are the forecasts/targets for the PIPR price?
Analysts Target Price 80.9 26.8%
Piper Sandler Companies (PIPR) - Fundamental Data Overview as of 08 October 2026
Market Cap USD = 4.64b (4.64b USD * 1.0 USD.USD)
P/E Trailing = 15.2343
P/E Forward = 10.1112
P/S = 2.1937
P/B = 3.7113
P/EG = 1.2623
Revenue TTM = 2.10b USD
EBIT TTM = 487.0m USD
EBITDA TTM = 515.6m USD
Long Term Debt = 160.0m USD (estimated: total debt 175.0m - short term 15.0m)
Short Term Debt = 15.0m USD (from shortTermDebt, last quarter)
Debt = 335.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 160.0m
Net Debt = 30.8m USD (calculated: Debt 335.0m - CCE 304.2m)
Enterprise Value = 4.67b USD (4.64b + Debt 335.0m - CCE 304.2m)
Interest Coverage Ratio = 150.5 (Ebit TTM 487.0m / Interest Expense TTM 3.23m)
EV/FCF = 7.73x (Enterprise Value 4.67b / FCF TTM 604.5m)
FCF Yield = 12.94% (FCF TTM 604.5m / Enterprise Value 4.67b)
FCF Margin = 28.78% (FCF TTM 604.5m / Revenue TTM 2.10b)
Net Margin = 14.63% (Net Income TTM 307.3m / Revenue TTM 2.10b)
 Gross Margin = unknown ((Revenue TTM 2.10b - Cost of Revenue TTM 73.6m) / Revenue TTM)
 Tobins Q-Ratio = 2.01 (Enterprise Value 4.67b / Total Assets 2.33b)
Interest Expense / Debt = 0.97% (Interest Expense 3.23m / Debt 335.0m)
Taxrate = 24.91% (120.7m / 484.6m)
NOPAT = 365.7m (EBIT 487.0m * (1 - 24.91%))
Current Ratio = 2.09 (Total Current Assets 1.09b / Total Current Liabilities 518.9m)
Debt / Equity = 0.24 (Debt 335.0m / totalStockholderEquity, last quarter 1.37b)
Debt / EBITDA = 0.06 (Net Debt 30.8m / EBITDA 515.6m)
Debt / FCF = 0.05 (Net Debt 30.8m / FCF TTM 604.5m)
Total Stockholder Equity = 1.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.34% (Net Income 307.3m / Total Assets 2.33b)
RoE = 22.90% (Net Income TTM 307.3m / Total Stockholder Equity 1.34b)
RoCE = 32.42% (EBIT 487.0m / Capital Employed (Equity 1.34b + L.T.Debt 160.0m))
RoIC = 21.29% (NOPAT 365.7m / Invested Capital 1.72b)
WACC = 9.99% (E(4.64b)/V(4.98b) * Re(10.66%) + D(335.0m)/V(4.98b) * Rd(0.97%) * (1-Tc(0.25)))
Discount Rate = 10.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 54.76 | Cagr: 0.77%
[DCF] Terminal Value 72.85% ; FCFF base≈375.8m ; Y1≈430.8m ; Y5≈634.0m
[DCF] Fair Price = 104.2 (EV 7.40b - Net Debt 30.8m = Equity 7.37b / Shares 70.7m; r=9.99% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.46 | EPS CAGR: 34.33% | SUE: 1.10 | # QB: 1
Revenue Correlation: 97.02 | Revenue CAGR: 19.67% | SUE: 0.94 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.94 | Chg30d=+0.43% | Revisions=-62% | Analysts=5
EPS current Year (2026-12-31): EPS=4.62 | Chg30d=-0.22% | Revisions=-29% | GrowthEPS=+4.2% | GrowthRev=+10.9%
EPS next Year (2027-12-31): EPS=5.49 | Chg30d=-0.69% | Revisions=+0% | GrowthEPS=+18.9% | GrowthRev=+12.4%
[Analyst] Revisions Ratio: -44% (up=3, down=10)